Legal Issues

Angiotech wins patent infringement case in the Netherlands

Published in Drug Law Weekly, February 20th, 2007

Angiotech Pharmaceuticals, Inc. (ANPI, ANP) announced that they received a favorable decision from a Dutch Court in a patent dispute against Conor Medsystems, Inc.

The District Court in The Hague held that Conor's CoStar paclitaxel stent infringes a key claim of the Dutch version of an important Angiotech European stent patent, and that Conor is therefore immediately enjoined from selling CoStar in the Netherlands.

"This is a significant victory in a key area of our intellectual property," said William L. Hunter, president and CEO of Angiotech. "Conor's attempt to design around our patented technology has failed. Not only did the Court uphold...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Drug Law Weekly

Source: Drug Law Weekly (2007-02-20)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry